Laryngeal Transplantation

  • Robert R. Lorenz
  • Marshall Strome

The concept of human laryngeal transplantation was first introduced into the literature in the 1960s, with experiments using the dog model by Boles, Ogura, and Silver. In 1969, Kluyskens attempted to treat a laryngeal cancer by transplantation. This transplant was subtotal, preserving recipient perichondrium to revascularize the donor organ without the use of vascular or neural anastomoses. The rapid recurrence of the tumor quashed interest in the procedure for nearly two decades.


Donor Organ Recurrent Laryngeal Nerve Laryngeal Nerve Mycophenolate Mofetil Vocal Fold 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R. Boles, Surgical replantation of the larynx in dogs: a progress report, Laryngoscope 76, 1057–1067 (1966).PubMedGoogle Scholar
  2. 2.
    J. H. Ogura, M. Kawasaki, S. Takenouchi, e al., Replantation and transplantation of the canine larynx, Ann Otol Rhino Laryng 75, 295–312 (1966).Google Scholar
  3. 3.
    G. E. Silver, P. S. Lieber, M. L. Som, Autologous transplantation of the canine larynx, Arch Otolaryngol 86, 95–102 (1967).PubMedGoogle Scholar
  4. 4.
    P. Kluyskens, S. Ringoir, Follow-up of a human larynx transplantation, Laryngoscope 80, 1244–1250 (1970).PubMedCrossRefGoogle Scholar
  5. 5.
    M. Strome, J. Wu, S. Stome, et al., A comparison of preservation techniques in a vascularized rat laryngeal transplant model, Laryngoscope 104, 666–668 (1994).PubMedCrossRefGoogle Scholar
  6. 6.
    S. Strome, G. Brodsky, J. Darrell, et al., Histopathologic correlates of acute laryngeal allograft rejection in a rat model, Ann Otol Rhinol Laryngol 101, 156–160 (1992).PubMedGoogle Scholar
  7. 7.
    M. Strome, S. Strome, J. Darrell, et al., The effects of cyclosporin A on transplanted rat allografts, Laryngoscope 103, 394–398 (1993).PubMedCrossRefGoogle Scholar
  8. 8.
    M. Strome, J. Stein, R. Esclamado, D. Hicks, R. R. Lorenz, W. Braun, R. Yetman, I. Eliachar, J. Mayes, Laryngeal transplantation: a case report with three-year follow-up, N Engl J Med 344, 1676–1679 (2001).PubMedCrossRefGoogle Scholar
  9. 9.
    R. R. Lorenz, D. M. Hicks, R. W. Sheilds, M. A. Fritz, M. Strome, Laryngeal nerve function after total laryngeal transplantation, Otolaryngol – Head Neck Surg 131(6), 1016–1018 (2004).PubMedCrossRefGoogle Scholar
  10. 10.
    K. F. Kevorkian, J. A. Sercarz, M. Ye, Y. M. Kim, K. H. Hong, G. S. Berke, Extended canine laryngeal preservation for transplantation, Laryngoscope 107(12 Pt 1), 1623–1626 (1997).PubMedCrossRefGoogle Scholar
  11. 11.
    E. M. Genden, A. Iskander, J. S. Bromberg, L. Mayer, The kinetics and pattern of tracheal allograft re-epithelialization, Am J Respir Cell Mol Biol 28(6), 673–681 (2003).PubMedCrossRefGoogle Scholar
  12. 12.
    M. A. Birchall, M. Bailey, E. V. Barker, H. J. Rothkotter, K. Otto, P. Macchiarini, Model for experimental revascularized laryngeal allotransplantation, Br J Surg 89(11), 1470–1475 (2002).PubMedCrossRefGoogle Scholar
  13. 13.
    R. R. Lorenz, O. Dan, M. A. Fritz, M. Strome, The rat laryngeal transplant model: technical advancements and a re-defined rejection grading system, Ann Otol, Rhinol Laryngol 111(12), 1120–1127 (2002).Google Scholar
  14. 14.
    M. Nelson, O. Dan, M. Strome, Evaluation of parathyroid hormone as a functional biological marker of rat laryngeal transplant rejection, Laryngoscope 113(9) (2003).Google Scholar
  15. 15.
    S. W. Barthel, O. Dan, J. Myles, et al., Effect of in vitro irradiation of donor larynges on cyclosporine requirements and rejection rates in rat laryngeal transplantation, Ann Otol Rhinol Laryngol 110, 20–24 (2001).PubMedGoogle Scholar
  16. 16.
    R. R. Lorenz, O. Dan, M. Haug, et al., Immunosuppressive effect of irradiation in the murine laryngeal transplantation model: a controlled trial, Ann Otol Rhinol Laryngol 112(8), 712–715 (2003).PubMedGoogle Scholar
  17. 17.
    M. Haug, O. Dan, S. Wimberley, M. Fritz, R. R. Lorenz, M. Strome, Cyclosporine dose, serum trough levels, and allograft preservation in a rat model of laryngeal transplantation, Ann Otol Rhinol Laryngol 112(6), 506–510 (2003).PubMedGoogle Scholar
  18. 18.
    M. Nelson, M. Fritz, O. Dan, S. Worley, M. Strome, Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation, Laryngoscope 113(8), 1308–1313 (2003).PubMedCrossRefGoogle Scholar
  19. 19.
    L. M. Akst, M. Siemionow, O. Dan, D. Izycki, M. Strome, Induction of tolerance in a rat model of laryngeal transplantation, Transplantation 76(12), 1763–1770 (2003).PubMedCrossRefGoogle Scholar
  20. 20.
    E. M. Genden, S. E. Mackinnon, S. Yu, D. A. Hunter, M. W. Flye, Portal venous ultraviolet B-irradiated donor alloantigen prevents rejection in circumferential rat tracheal allografts, Otolaryngol Head Neck Surg 124(5), 481–488 (2001).PubMedCrossRefGoogle Scholar
  21. 21.
    G. K. Gorti, M. A. Birchall, K. Haverson, P. Macchiarini, M. Bailey, A preclinical model for laryngeal transplantation: anatomy and mucosal immunology of the porcine larynx, Transplantation 68(11), 1638–1642 (1999).PubMedCrossRefGoogle Scholar
  22. 22.
    L. E. Rees, O. Ayoub, K. Haverson, M. A. Birchall, M. Bailey, Differential major histocompatibility complex class II locus expression on human laryngeal epithelium, Clin Exp Immunol 134(3), 497–502 (2003).PubMedCrossRefGoogle Scholar
  23. 23.
    S. Govindaraj, R. Gordon, E. M. Genden, Effect of fibrin matrix and vascular endothelial growth factor on re-epithelialization of orthotopic murine tracheal transplants, Ann Otol Rhinol Laryngol 113(10), 797–804 (2004).PubMedGoogle Scholar
  24. 24.
    P. Stavroulaki, M. Birchall, Comparative study of the laryngeal innervation in humans and animal employed in laryngeal transplantation research, J Laryngol Otol 115, 257–266 (2001).PubMedCrossRefGoogle Scholar
  25. 25.
    J. H. Blumin, M. Ye, G. S. Berke, et al., Recovery of laryngeal sensation after superior laryngeal nerve anastomosis, Laryngoscope 109, 1637–1641 (1999).PubMedCrossRefGoogle Scholar
  26. 26.
    K. L. Peterson, R. J. Andrews, J. A. Sercarz, et al., Comparison of nerve banking techniques in delayed laryngeal reinnervation, Ann Otol Rhinol Laryngol 108, 689–694 (1999).PubMedGoogle Scholar
  27. 27.
    R. J. Andrews, G. S. Berke, K. E. Blackwell, et al., Hemilaryngeal transplantation in the canine model: technique and implications, Am J Otolaryngol 21, 85–91 (2000).PubMedCrossRefGoogle Scholar
  28. 28.
    M. A. Birchall, R. R. Lorenz, E. M. Genden, B. H. Haughey, M. Siemionow, M. Strome, Laryngeal transplantation in 2005: a review, American Journal of Transplantation 6(1), 20–26 (2006).PubMedCrossRefGoogle Scholar
  29. 29.
    I. Penn, Occurrence of cancers in immunosuppressed organ transplant recipients, Clin Transplant 47–158 (1998).Google Scholar
  30. 30.
    R. Sedrani, S. Cottens, J. Kallen, W. L. Schuler, Chemical modification of rapamycin: the discovery of SDZ RAD, Transpl Proc 30, 2192–2194 (1998).CrossRefGoogle Scholar
  31. 31.
    A. Boulay, S. Zumstein-Mecker, C. Stephan, Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells, Cancer Res 64, 252–261 (2004).PubMedCrossRefGoogle Scholar
  32. 32.
    P. D. Knott, M. Nelson, O. Dan, F. Van Lente, M. Strome, Immunosuppressive efficacy of everolimus and tacrolimus combination therapy in a rat laryngeal transplant model (submitted for publication).Google Scholar
  33. 33.
    S. S. Khariwala, P. D. Knott, O. Dan, et al., Pulsed immunosuppression with everolimus and anti-alphabeta T-cell receptor: laryngeal allograft preservation at six months. Annals of Otology, Rhinology & Laryngology. 115(1): 74–80, 2006 Jan.Google Scholar
  34. 34.
    S. S. Khariwala, J. Kjaergaard, R. R. Lorenz, F. Van Lente, S. Shu, M. Strome, Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (sec VII). Laryngoscope 116(5): 814–820 (2006).PubMedCrossRefGoogle Scholar
  35. 35.
    A. P. Monaco, Transplantation of the larynx: a case report that speaks for itself, N Engl J Med 344, 1712–1714 (2001).PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Robert R. Lorenz
    • 1
  • Marshall Strome
    • 1
  1. 1.The Cleveland Clinic FoundationCleveland Clinic Lerner College of Medicine of Case Western Reserve UniversityCleveland

Personalised recommendations